Skip to main content
Have a personal or library account? Click to login
Cytoprotective potential of anti-ischemic drugs against chemotherapy-induced cardiotoxicity in H9c2 myoblast cell line Cover

Cytoprotective potential of anti-ischemic drugs against chemotherapy-induced cardiotoxicity in H9c2 myoblast cell line

Acta Pharmaceutica
Volume 63 (2013): Issue 4 (December 2013)
By: ,  ,  ,   and    
Open Access
|Dec 2013
References

References

  1. 1. W. A. Denny, Emerging DNA topisomerase inhibitors as anticancer drugs, Expert Opin. Emerg. Drugs(2004) 105-133; DOI: 10.1517/eoed.9.1.105.32948.
    Open DOISearch in Google Scholar
  2. 2. L. F. Liu, DNA topoisomerase poisons as antitumor drugs, Annu. Rev. Biochem.(1989) 351-375; DOI: 10.1146/annurev.bi.58.070189.002031.
    Open DOISearch in Google Scholar
  3. 3. G. Takemura and H. Fujiwara, Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management, Prog. Cardiovasc. Dis.(2007) 330-352; DOI: 10.1016/j.pcad.2006.10.002.
    Open DOISearch in Google Scholar
  4. 4. S. Hitchcock-Bryan, R. Gelber, J. R. Cassady and S. E. Sallan, The impact of induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia, Med. Pediatr. Oncol.(1986) 211-215; DOI: http://dx.doi.org/10.1002/mpo.2950140405.
    Open DOISearch in Google Scholar
  5. 5. T. Feridooni, A. Hotchkiss, S. Remley-Carr, Y. Saga and K. B. S. Pasumarthi, Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes, PLoS ONE(2011) e22801; DOI:10.1371/journal.pone.0022801.
    Open DOISearch in Google Scholar
  6. 6. X. Z. Han, S. Gao, Y. N. Cheng, Y. Z. Sun, W. Liu, L. L. Tang and D. M. Ren, Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes, Biosci. Trends(2012) 19-25; DOI: 10.5582/bst.2012.v6.1.19.
    Open DOISearch in Google Scholar
  7. 7. B. Glimelius, Benefit-risk assessment of irinotecan in advanced colorectal cancer, Drug Saf.(2005) 417-433; DOI: http://dx.doi.org/10.2165/00002018-200528050-00005.
    Open DOISearch in Google Scholar
  8. 8. J. Weekes, A. K.-Y. Lam, S. Sebesan and Y.-H. Ho, Irinotecan therapy and molecular targets in colorectal cancer: a systemic review, World J. Gastroenterol.(2009) 3597-3602; DOI: http://dx.doi.org/10.3748/wjg.15.3597.
    Open DOISearch in Google Scholar
  9. 9. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo and L. Gianni, Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity, Pharmacol. Rev.(2004) 185-229; DOI: 10.1124/pr.56.2.6.
    Open DOISearch in Google Scholar
  10. 10. R. Nithipongvanitch, W. Ittarat, M. P. Cole, J. Tangpong, D. K. S. Clair and T. D. Oberley, Mitochondrial and nuclear p53 localization in cardiomyocytes: redox modulation by doxorubicin (Adriamycin)?, Antioxid. Redox Signal.(2007) 1001-1008; DOI:10.1089/ars.2007.1632.
    Open DOISearch in Google Scholar
  11. 11. E. H. Herman and V. J. Ferrans, Amelioration of chronic anthracycline cardiotoxicity by ICRF- -187 and other compounds, Cancer Treat Rev.(1987) 225-259; DOI: 10.1016/0305-7372(87) 90011-9.
    Search in Google Scholar
  12. 12. S. M. Swain, F. S. Whaley, M. C. Gerber, M. S. Ewer, J. R. Bianchine and R. A. Gams, Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy, J. Clin. Oncol.(1997) 13331340.
    Search in Google Scholar
  13. 13. S. M. Swain and P. Vici, The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review, J. Cancer Res. Clin. Oncol.(2004) 1-7; DOI: 10. 1007/s00432-003-0498-7.
    Open DOISearch in Google Scholar
  14. 14. M. S. Wolin, Interactions of oxidants with vascular signaling systems, Arterioscl. Throm. Vas.Biol.(2000) 1430-1442; DOI: 10.1161/01.ATV.20.6.1430.
    Open DOISearch in Google Scholar
  15. 15. D. B. Sawyer, R. Fukazawa, M. A. Arstall and R. A. Kelly, Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane, Circ. Res.(1999) 257-65; DOI: 10.1161/01.RES.84.3.257.
    Open DOISearch in Google Scholar
  16. 16. J. Bierau, R. Leen, A. H. van Gennip, H. N. Caron and A. B. P. van Kuilenburg, Determination of the deoxycytidine kinase activity in cell homogenates with a non-radiochemical assay using reversed- phase high performance liquid chromatography; Identification of a novel metabolite of 2-chlorodeoxyadenosine, J. Chromatogr. B(2004) 339-346; DOI: 10.1016/j.jchromb.2004.03.036.
    Open DOISearch in Google Scholar
  17. 17. B. Diop-Frimpong, V. P. Chauhan, S. Krane, Y. Boucher and R. K. Jain, Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors, Proc. Natl. Acad. Sci. USA(2011) 2909-2914; DOI: 10.1073/pnas.1018892108.
    Open DOISearch in Google Scholar
  18. 18. C. E. Runyan, H. W. Schnaper and A.-C. Poncelet, The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells, J. Biol. Chem.(2005) 8300-8308; DOI: 10.1074/jbc.M407939200.
    Open DOISearch in Google Scholar
  19. 19. K. Tamaki, S. Okuda, T. Ando, T. Iwamoto, M. Nakayama and M. Fujishima, TGF-beta 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy, Kidney Int.(1994) 525-536.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/acph-2013-0038 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 493 - 503
Published on: Dec 31, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
rat myoblast (H9c2),
cytoprotection,
dexrazoxane,
doxorubicin,
diltiazem,
irinotecan
Related subjects:
Pharmacy,
Pharmacy, other

© 2013 Tiam Feridooni, Chris Mac Donald, Di Shao, Pollen Yeung, Remigius U. Agu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 63 (2013): Issue 4 (December 2013)
Previous article
Next article